Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (7): 768-769.DOI: 10.3969/j.issn.1673-8640.2015.07.023
• Orginal Article • Previous Articles Next Articles
Received:2014-08-18
Online:2015-07-30
Published:2015-08-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.07.023
| 样本 | 批内 | 批间 | ||||||
|---|---|---|---|---|---|---|---|---|
| s(ng/mL) | CV(%) | 厂商CV(%) | s(ng/mL) | CV(%) | 厂商CV(%) | |||
| 低值 | 0.560 | 0.007 | 1.25 | 1.28 | 0.580 | 0.019 | 3.28 | 3.74 |
| 高值 | 16.050 | 0.409 | 2.55 | 2.70 | 16.330 | 0.831 | 5.09 | 7.86 |
| 样本 | 批内 | 批间 | ||||||
|---|---|---|---|---|---|---|---|---|
| s(ng/mL) | CV(%) | 厂商CV(%) | s(ng/mL) | CV(%) | 厂商CV(%) | |||
| 低值 | 0.560 | 0.007 | 1.25 | 1.28 | 0.580 | 0.019 | 3.28 | 3.74 |
| 高值 | 16.050 | 0.409 | 2.55 | 2.70 | 16.330 | 0.831 | 5.09 | 7.86 |
| 稀释比例(高:低) | 测定结果 | 理论结果 |
|---|---|---|
| 5:0 | 27.83 | 27.83 |
| 4:1 | 21.62 | 22.27 |
| 3:2 | 16.11 | 16.70 |
| 2:3 | 10.61 | 11.14 |
| 1:4 | 5.10 | 5.57 |
| 0:5 | 0.01 | 0.01 |
| 稀释比例(高:低) | 测定结果 | 理论结果 |
|---|---|---|
| 5:0 | 27.83 | 27.83 |
| 4:1 | 21.62 | 22.27 |
| 3:2 | 16.11 | 16.70 |
| 2:3 | 10.61 | 11.14 |
| 1:4 | 5.10 | 5.57 |
| 0:5 | 0.01 | 0.01 |
| [1] | Thygesen K,Alpert JS,White HD,et al.Universal definition of myocardial infarction[J].Circulation,2007,116(22):2634-2653. |
| [2] | 宋凌燕,吴炯,郭玮.高敏感心肌肌钙蛋白检测方法的临床应用[J].检验医学,2010,25(8):664-668. |
| [3] | Clinical and Laboratory Standards Institute.Evaluation of precision performance of quantitative measurement methods;approved guideline-second edition[S]. EP5-A2,CLSI,2004. |
| [4] | Clinical and Laboratory Standards Institute.Evaluation of the linearity of quantitative measurement procedures:a statistical approach;approved guideline[S]. EP6-A,CLSI,2003. |
| [5] | Clinical and Laboratory Standards Institute.Interference testing in clinical chemistry;approved guideline-second edition[S].EP7-A2,CLSI,2005. |
| [6] | Clinical and Laboratory Standards Institute.Method comparison and bias estimation using patient samples;approved guideline-second edition[S].EP9-A2,CLSI,2010. |
| [7] | Clinical and Laboratory Standards Institute. How to define and determine reference intervals in the clinical laboratory;approved guideline second edition[S]. C28-A2,CLSI,2010. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
